GO:0051351 positive regulation of ligase activity

GO:0051351, positive regulation of ligase activity, is a Gene Ontology biological process term that captures any process which activates or increases the frequency, rate or extent of ligase activity. Ligases catalyze the joining of two substances with concomitant breaking of a diphosphate linkage, usually in a nucleoside triphosphate, and their positive regulation is essential for diverse cellular decisions including protein degradation, DNA repair, immune signaling, and metabolic homeostasis. Because ligase activity is often the rate-limiting step in ubiquitin transfer, cells deploy dedicated activators, adaptors, and post-translational modifications to switch ligases on or off. Understanding positive regulation of ligase activity therefore provides mechanistic insight into how cells convert external cues into durable changes in protein stability and signaling output. Research on this term spans plant phytochrome signaling, mammalian immunity, cardiovascular biology, and crop stress tolerance. For example, phytochrome signaling networks integrate light cues with ubiquitin-ligase-dependent degradation of transcription factors, illustrating how positive regulation of ligase activity shapes developmental programs. In mammalian systems, the ubiquitin ligase KLHL6 drives resistance to CD8+ T cell dysfunction, showing that ligase activation can directly influence immune cell fate and tumor control. Similarly, RNF138 regulates skeletal muscle differentiation via Wnt/beta-catenin signaling, and TaGW2-TaVOZ1 modules regulate wheat salt tolerance through both E3 ligase-dependent and -independent pathways. These examples highlight that positive regulation of ligase activity is not a generic housekeeping function but a tunable node that can be targeted for therapeutic or agricultural benefit. This article synthesizes authoritative QuickGO annotation for GO:0051351 with verified PubMed literature to describe the definition, mechanisms, key genes, disease links, and experimental methods used to study positive regulation of ligase activity. It is intended for researchers designing CRISPR models, interpreting multi-omics data, or seeking to modulate ligase activity in cancer, metabolic disease, and regenerative contexts.

In simple terms, GO:0051351 describes the cellular processes that turn ligase enzymes up, making them more active or more frequently used. The QuickGO definition states that this term covers any process that activates or increases the frequency, rate or extent of ligase activity, where ligase activity is the catalysis of the ligation of two substances with concomitant breaking of a diphosphate linkage, usually in a nucleoside triphosphate. This includes mechanisms such as allosteric activation, post-translational modification, cofactor availability, substrate recruitment, and stabilization of the ligase complex. Positive regulation of ligase activity is distinct from ligase expression alone because it specifically concerns the functional activation of the enzyme, although increased expression can contribute to increased activity.

Positive regulation of ligase activity is important because ligases control the timing and specificity of protein modification, degradation, and signaling, and their activation is often the decisive step that converts a transient cellular signal into a lasting biological outcome. Dysregulation of ligase-activating processes can drive cancer immune evasion, cardiovascular disease, and developmental defects, while controlled activation can support immune resistance and stress tolerance. For researchers, GO:0051351 provides a framework to identify activators, adaptors, and post-translational modifiers that tune ligase function, and to design CRISPR models that test causality in disease-relevant contexts.

The following genes and proteins represent real, literature-supported components and regulators associated with positive regulation of ligase activity across human, animal, and plant systems.

Positive regulation of ligase activity is itself regulated at multiple levels. Post-translational modifications, adaptor binding, and metabolic cues can switch ligases on or off. Cereblon's E3 ubiquitin ligase activity and binding efficiency with AMPK are under positive selection, indicating that metabolic sensors can influence ligase activation. Phytochrome signaling networks provide a plant example where light cues regulate ligase-dependent degradation of transcription factors. In immune and metabolic contexts, ACSL6-IL-18R1-NF-kB signaling and ACSL4 ubiquitination illustrate how lipid metabolism and cytokine pathways feed into ligase regulation. SIRT6 protects smooth muscle cells from senescence, suggesting that sirtuin-dependent processes can modulate ligase-related outcomes. TaGW2-TaVOZ1 modules in wheat show that ligase regulation can be integrated with salt-stress signaling through both E3 ligase-dependent and -independent pathways.

Positive regulation of ligase activity is directly implicated in cancer immune evasion. KLHL6, a ubiquitin ligase, drives resistance to CD8+ T cell dysfunction, suggesting that activating this ligase can preserve anti-tumor T cell function. ACSL6-activated IL-18R1-NF-kB signaling promotes IL-18-mediated tumor immune evasion and tumor progression, linking metabolic-ligase crosstalk to immune escape. These findings position ligase-activating modules as candidate targets for immunotherapy combination strategies.

SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis, connecting positive regulation of ligase-related processes to vascular protection. Loss of such protective regulation may accelerate smooth muscle cell senescence and plaque progression. This provides a rationale for studying ligase-activating pathways in cardiovascular disease models.

Inhibition of LPL suppresses osteoclast differentiation of bone-marrow-derived macrophages by promoting ACSL4 ubiquitination, showing that ligase activation can restrain osteoclastogenesis. This links positive regulation of ligase activity to bone homeostasis and potential therapies for bone loss.

RNF138 regulates skeletal muscle differentiation via the Wnt/beta-catenin signaling pathway, indicating that ligase activation is required for proper muscle development. Dysregulation of this module may contribute to muscle differentiation defects and impaired regeneration.

Ubiquitin enrichment coupled with mass spectrometry measures the ubiquitylation status of substrates after manipulating ligase activators. This approach can reveal whether positive regulation of ligase activity increases substrate ubiquitylation in models such as KLHL6-expressing T cells or ACSL4-dependent macrophages. Proteomics can also identify new substrates and adaptors that respond to ligase activation.

RNA sequencing after knockout or overexpression of ligase regulators identifies downstream transcriptional programs. For example, ACSL6-IL-18R1-NF-kB signaling and RNF138-Wnt/beta-catenin pathways can be mapped by transcriptomic profiling. Pathway enrichment helps connect positive regulation of ligase activity to immune, metabolic, and differentiation programs.

CRISPR library screening enables unbiased discovery of genes that positively regulate ligase activity. Screens can use ubiquitin reporters, degradation sensors, or immune resistance readouts to identify activators and adaptors. Hits can then be validated with focused knockout or point-mutation models.

Fluorescence imaging of ubiquitin or ligase localization, combined with biochemical assays such as in vitro ubiquitylation, measures the direct impact of positive regulators on ligase activity. These methods are useful for confirming that a candidate gene causally increases ligase function rather than merely correlating with it.

Researchers studying positive regulation of ligase activity-related genes often need to determine whether a candidate gene is causally involved in activating ligase function, rather than merely correlating with it. Establishing causality requires precise genetic models that can remove, modify, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides end-to-end CRISPR services to generate such models and to interpret the resulting phenotypes with bioinformatics support.

GO:0051351 positive regulation of ligase activity is a mechanistically rich biological process that controls ubiquitin-dependent protein fate, immune signaling, metabolic homeostasis, and plant stress responses. Real literature shows that ligase activators such as KLHL6, RNF138, cereblon, and TaGW2 are causally linked to T cell function, muscle differentiation, evolutionary adaptation, and salt tolerance. Understanding how these activators are themselves regulated will be key to therapeutic and agricultural applications. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with ubiquitin proteomics and transcriptomics, provide a rigorous path to dissect positive regulation of ligase activity in disease-relevant systems. EDITGENE's integrated services support researchers from hypothesis to validated mechanism, enabling reproducible and publication-ready discoveries in this rapidly expanding field.